Varda raises $251 million to scale pharmaceutical processing in space on October 01, 2026 Lux Capital Microgravity Natural pharmaceutical processing Series D Varda Space Industries +
Lilly’s amylin–Zepbound combination shows up to 23.3% weight loss on October 01, 2026 Diabetes Mellitus, Non-Insulin-Dependent Eli Eli Lilly eloralintide EloraTZP Obesity tirzepatide Zepbound +
Mironid begins dosing in first-in-human ADPKD drug trial on October 01, 2026 cyclic AMP LoAc Mironid MR-L45 Phase 1 (qualifier value) Polycystic Kidney, Autosomal Dominant +
Merck’s anti-TL1A drug shows promising Phase 2b results in hidradenitis suppurativa on October 01, 2026 anti-TL1A Hidradenitis Suppurativa Merck tulisokibart +
Ceribell wins FDA clearance for new EEG trending and analysis features on October 01, 2026 amplitude-integrated EEG Burst suppression Ceribell Clearance quantitative EEG United States Food and Drug Administration +
Recent U.S. news: HR-positive/HER2-negative breast cancer on October 01, 2026 approvals camizestrant CDK4/6 inhibitors ESR1 gene gedatolisib HR-positive/HER2-negative breast cancer imlunestrant mutation testing United States United States Food and Drug Administration +
KOL Insight: NSCLC Targeted Therapies — key takeaways on October 01, 2026 amivantamab erbB-2 Receptor KOL Insight Non-Small Cell Lung Carcinoma osimertinib targeted therapies trastuzumab +
Kither Biotech begins patient dosing in KIT2014 COPD trial on October 01, 2026 Clinical Trials COPD inhaled therapy Kither Biotech +